Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

BTLA anticorps

L’anticorps Rat Monoclonal anti-BTLA a été validé pour FACS. Il convient pour détecter BTLA dans des échantillons de Souris.
N° du produit ABIN7457869

Aperçu rapide pour BTLA anticorps (ABIN7457869)

Antigène

Voir toutes BTLA Anticorps
BTLA (B and T Lymphocyte Associated (BTLA))

Reactivité

  • 79
  • 34
  • 2
  • 2
  • 1
  • 1
Souris

Hôte

  • 41
  • 40
  • 9
  • 4
  • 1
  • 1
  • 1
Rat

Clonalité

  • 56
  • 39
  • 2
Monoclonal

Conjugué

  • 49
  • 6
  • 6
  • 5
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp BTLA est non-conjugé

Application

  • 51
  • 45
  • 30
  • 13
  • 13
  • 9
  • 8
  • 7
  • 7
  • 6
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
Flow Cytometry (FACS)

Clone

PK18-6
  • Purification

    Purified

    Isotype

    IgG1, kappa
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Commentaires

    Matching Isotype Control: Purified Rat IgG1, κ Isotype Control (ABIN7469819)

    Restrictions

    For Research Use only
  • Concentration

    0.5 mg/mL

    Buffer

    PBS with 0.05 % Proclin300

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C

    Stockage commentaire

    Store at 2~8°C. Do not freeze.
  • Antigène

    BTLA (B and T Lymphocyte Associated (BTLA))

    Autre désignation

    CD272

    Sujet

    B- and T-lymphocyte attenuator,Btla,B- and T-lymphocyte-associated protein,CD272,Btla,CD272, also known as B and T lymphocyte attenuator (BTLA), is an Ig superfamily co-inhitory receptor with structural similarity to programmed cell death 1 (PD-1) and CTLA-4. BTLA is expressed on B cells, T cells, macrophages, dendritic cells, NKT cells, and NK cells. Engagement of BTLA by its ligand herpes virus entry mediator (HVEM) is critical for negatively regulating immune response. The absence of BTLA with HVEM inhibitory interactions leads to increased experimental autoimmune encephalomyelitis severity, enhanced rejection of partially mismatched allografts, an increased CD8+ memory T cell population, increased severity of colitis, and reduced effectiveness of T regulatory cells. BTLA plays an important role in the induction of peripheral tolerance of both CD4+ and CD8+ T cells in vivo. Tolerant T cells have significantly higher expression of BTLA compared with effectors and naive T cells. BTLA may cooperate with CTLA-4 and PD-1 to control T cell tolerance and autoimmunity. It was reported that BTLA may regulate T cell function by binding to B7-H4, but further studies are needed to confirm. The existence of three distinct BTLA alleles has been reported.

    ID gène

    208154

    UniProt

    Q7TSA3

    Pathways

    Cancer Immune Checkpoints
Vous êtes ici:
Chat with us!